{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:05:45Z","timestamp":1778882745720,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 NS44233"],"award-info":[{"award-number":["P01 NS44233"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 NS065736"],"award-info":[{"award-number":["U54 NS065736"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS092625"],"award-info":[{"award-number":["R01 NS092625"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23 NS075141"],"award-info":[{"award-number":["K23 NS075141"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR000135"],"award-info":[{"award-number":["UL1 TR000135"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009210","name":"Food and Drug Administration","doi-asserted-by":"publisher","award":["R01 FD004789"],"award-info":[{"award-number":["R01 FD004789"]}],"id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.mayocp.2018.05.033","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T17:21:46Z","timestamp":1535476906000},"page":"1440-1447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Ganglionic Antibody Level as a Predictor of Severity of Autonomic Failure"],"prefix":"10.1016","volume":"93","author":[{"given":"Jeremy K.","family":"Cutsforth-Gregory","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"McKeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Coon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Sletten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Sandroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo E.","family":"Benarroch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Fealey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip A.","family":"Low","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mayocp.2018.05.033_bib1","first-page":"355","article-title":"Pure pan-dysautonomia with recovery","volume":"94","author":"Young","year":"1969","journal-title":"Trans Am Neurol Assoc"},{"issue":"6","key":"10.1016\/j.mayocp.2018.05.033_bib2","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1212\/WNL.50.6.1806","article-title":"Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes","volume":"50","author":"Vernino","year":"1998","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.mayocp.2018.05.033_bib3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM200009213431204","article-title":"Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies","volume":"343","author":"Vernino","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2018.05.033_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2008.03.017","article-title":"Characterization of ganglionic acetylcholine receptor autoantibodies","volume":"197","author":"Vernino","year":"2008","journal-title":"J\u00a0Neuroimmunol"},{"issue":"1-2","key":"10.1016\/j.mayocp.2018.05.033_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.autneu.2008.11.013","article-title":"Antibody titers predict clinical features of autoimmune autonomic ganglionopathy","volume":"146","author":"Gibbons","year":"2009","journal-title":"Auton Neurosci"},{"issue":"9","key":"10.1016\/j.mayocp.2018.05.033_bib6","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/nmo.12391","article-title":"Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility","volume":"26","author":"Flanagan","year":"2014","journal-title":"Neurogastroenterol Motil"},{"issue":"1-2","key":"10.1016\/j.mayocp.2018.05.033_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.autneu.2008.10.022","article-title":"Other autonomic neuropathies associated with ganglionic antibody","volume":"146","author":"Sandroni","year":"2009","journal-title":"Auton Neurosci"},{"issue":"6","key":"10.1016\/j.mayocp.2018.05.033_bib8","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ana.10556","article-title":"The spectrum of autoimmune autonomic neuropathies","volume":"53","author":"Klein","year":"2003","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.mayocp.2018.05.033_bib9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/archneurol.2011.2372","article-title":"Autoimmune autonomic ganglionopathy with reversible cognitive impairment","volume":"69","author":"Gibbons","year":"2012","journal-title":"Arch Neurol"},{"issue":"1-2","key":"10.1016\/j.mayocp.2018.05.033_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.autneu.2008.10.016","article-title":"Autoimmune autonomic ganglionopathy with late-onset encephalopathy","volume":"146","author":"Baker","year":"2009","journal-title":"Auton Neurosci"},{"issue":"1-2","key":"10.1016\/j.mayocp.2018.05.033_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.autneu.2008.12.013","article-title":"Japanese case of autoimmune autonomic ganglionopathy (AAG) and a review of AAG cases in Japan","volume":"146","author":"Hayashi","year":"2009","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.mayocp.2018.05.033_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.autneu.2015.07.292","article-title":"Cardiovascular antibodies and orthostatic hypotension","volume":"192","author":"Cheshire","year":"2015","journal-title":"Auton Neurosci"},{"issue":"6","key":"10.1016\/j.mayocp.2018.05.033_bib13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archneurol.2009.78","article-title":"Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments","volume":"66","author":"McKeon","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mayocp.2018.05.033_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1196\/annals.1254.023","article-title":"Neuronal ganglionic acetylcholine receptor autoimmunity","volume":"998","author":"Vernino","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.mayocp.2018.05.033_bib15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.20269","article-title":"Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome","volume":"56","author":"Pittock","year":"2004","journal-title":"Ann Neurol"},{"issue":"1-2","key":"10.1016\/j.mayocp.2018.05.033_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneuroim.2005.03.020","article-title":"Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes","volume":"165","author":"Graus","year":"2005","journal-title":"J\u00a0Neuroimmunol"},{"issue":"9","key":"10.1016\/j.mayocp.2018.05.033_bib17","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4065\/81.9.1207","article-title":"Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction","volume":"81","author":"Pittock","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.mayocp.2018.05.033_bib18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/ana.21324","article-title":"Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G","volume":"63","author":"Keegan","year":"2008","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.mayocp.2018.05.033_bib19","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1561::AID-MUS11>3.0.CO;2-3","article-title":"Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects","volume":"20","author":"Low","year":"1997","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.mayocp.2018.05.033_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/1086508X.1999.11079251","article-title":"The autonomic laboratory","volume":"39","author":"Low","year":"1999","journal-title":"Am J Electroneurodiagnostic Technol"},{"issue":"6","key":"10.1016\/j.mayocp.2018.05.033_bib21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0025-6196(12)65338-5","article-title":"Thermoregulatory sweating abnormalities in diabetes mellitus","volume":"64","author":"Fealey","year":"1989","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.mayocp.2018.05.033_bib22","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0025-6196(12)60631-4","article-title":"Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure","volume":"68","author":"Low","year":"1993","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.mayocp.2018.05.033_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/archneurol.2007.60","article-title":"Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy","volume":"65","author":"Gibbons","year":"2008","journal-title":"Arch Neurol"},{"issue":"23","key":"10.1016\/j.mayocp.2018.05.033_bib24","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1212\/WNL.0b013e3181a92b52","article-title":"Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy","volume":"72","author":"Iodice","year":"2009","journal-title":"Neurology"},{"issue":"18","key":"10.1016\/j.mayocp.2018.05.033_bib25","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/WNL.0b013e3181bf995f","article-title":"Sudomotor dysfunction in autoimmune autonomic ganglionopathy","volume":"73","author":"Kimpinski","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.mayocp.2018.05.033_bib26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/ana.410130407","article-title":"Acute panautonomic neuropathy","volume":"13","author":"Low","year":"1983","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.mayocp.2018.05.033_bib27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.revmed.2010.01.008","article-title":"Autoimmune autonomic ganglionopathy: a case series of six patients and literature review [in French]","volume":"31","author":"Parize","year":"2010","journal-title":"Rev Med Interne"},{"issue":"9","key":"10.1016\/j.mayocp.2018.05.033_bib28","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1212\/WNL.44.9.1675","article-title":"Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients","volume":"44","author":"Suarez","year":"1994","journal-title":"Neurology"},{"issue":"1-2","key":"10.1016\/j.mayocp.2018.05.033_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.autneu.2007.05.005","article-title":"Dysfunction of the pupillary light reflex in experimental autoimmune autonomic ganglionopathy","volume":"137","author":"Mukherjee","year":"2007","journal-title":"Auton Neurosci"},{"issue":"3","key":"10.1016\/j.mayocp.2018.05.033_bib30","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mus.24559","article-title":"Clinical experience of seropositive ganglionic acetylcholine receptor antibody in a tertiary neurology referral center","volume":"52","author":"Li","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.mayocp.2018.05.033_bib31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1196\/annals.1405.011","article-title":"Neuronal acetylcholine receptor autoimmunity","volume":"1132","author":"Vernino","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.mayocp.2018.05.033_bib32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pediatrneurol.2010.05.003","article-title":"Isolated sympathetic failure with autoimmune autonomic ganglionopathy","volume":"43","author":"Fischer","year":"2010","journal-title":"Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.mayocp.2018.05.033_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10286-009-0012-7","article-title":"Autoimmune autonomic ganglionopathy: treatment by plasma exchanges and rituximab","volume":"19","author":"Imrich","year":"2009","journal-title":"Clin Auton Res"},{"issue":"1","key":"10.1016\/j.mayocp.2018.05.033_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/08916930701619987","article-title":"Antibodies to muscle and ganglionic acetylcholine receptors (AchR) in celiac disease","volume":"41","author":"Briani","year":"2008","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.mayocp.2018.05.033_bib35","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/mus.25027","article-title":"P\/Q- and N-type calcium-channel antibodies: oncological, neurological, and serological accompaniments","volume":"54","author":"Zalewski","year":"2016","journal-title":"Muscle Nerve"},{"issue":"1-2","key":"10.1016\/j.mayocp.2018.05.033_bib36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.autneu.2009.06.002","article-title":"Association of N-type calcium channel autoimmunity in patients with autoimmune autonomic ganglionopathy","volume":"150","author":"Kimpinski","year":"2009","journal-title":"Auton Neurosci"},{"issue":"1","key":"10.1016\/j.mayocp.2018.05.033_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archneur.61.1.44","article-title":"Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody","volume":"61","author":"Sandroni","year":"2004","journal-title":"Arch Neurol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618304622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618304622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:29:43Z","timestamp":1758418183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619618304622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0025619618304622"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.05.033","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ganglionic Antibody Level as a Predictor of Severity of Autonomic Failure","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}